What is the role of the enzyme Alpha-Galactosidase in the treatment of Fabry disease, a genetic disorder caused by the accumulation of globotriaosylceramide?
Explanation
Alpha-Galactosidase is the enzyme responsible for breaking down globotriaosylceramide. In Fabry disease, a deficiency in this enzyme leads to the accumulation of globotriaosylceramide, causing various symptoms. Enzyme replacement therapy with Alpha-Galactosidase can help alleviate these symptoms.
Source
Orphanet Journal of Rare Diseases











